<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63853">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02018237</url>
  </required_header>
  <id_info>
    <org_study_id>2011-12111</org_study_id>
    <nct_id>NCT02018237</nct_id>
  </id_info>
  <brief_title>High Fructose Corn Syrup</brief_title>
  <acronym>Fructose</acronym>
  <official_title>The Effect of High Fructose Corn Syrup Feeding in Nonalcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to learn more about high fructose corn syrup, a sugar
      used to sweeten drinks and foods, affects metabolism in obese persons with and without
      nonalcoholic fatty liver disease.  Eligible participants will be studied before and after
      eating a diet high in high fructose corn syrup or a a standard diet (low in high fructose
      corn syrup) for four weeks.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Change in intrahepatic triglyceride(IHTG)content</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determine the effect of 4-week isocaloric diet high in high fructose corn syrup (HFCS) on IHTG content measured by magnetic resonance spectroscopy (MRS).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hepatic lipid metabolism</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determine the effect of 4-week isocaloric diet high in HFCS on hepatic lipid metabolism [de novo lipogenesis, very low density lipoprotein-triglyceride (VLDL-TG) and very low density lipoprotein-Apolipoprotein B100 (VLDL-ApoB) secretion rates] by using stable isotope tracer methods.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Multi-organ insulin sensitivity</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determine the effect of 4-week isocaloric diet high in HFCS on multi-organ insulin sensitivity by using a one stage hyperinsulinemic euglycemic clamp procedure in conjunction with muscle and adipose tissue biopsies.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Uric acid metabolism</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determine the effect of 4-week isocaloric diet high in HFCS on uric acid metabolism by measuring post-prandial serum uric acid concentrations and using stable isotope tracer method.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Nonalcoholic Fatty Liver Disease</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>NAFLD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with nonalcoholic fatty liver disease (NAFLD) will complete baseline testing and then be assigned to either the high fructose corn syrup diet or the standard diet(low in high fructose corn syrup) for 4 weeks.  Post intervention testing will be completed after the subjects have completed the 4 week diet intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-NAFLD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects without nonalcoholic fatty liver disease (Non-NAFLD) will complete baseline testing and then be fed a high fructose corn syrup diet for 4 weeks. Post intervention testing will be completed after the subjects have completed the 4 week diet intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High fructose corn syrup diet</intervention_name>
    <description>Subjects will consume a high fructose corn syrup diet for 4 weeks.  The food will be prepared by the bionutrition kitchen and meals will be picked up every 3-4 days.</description>
    <arm_group_label>NAFLD</arm_group_label>
    <arm_group_label>Non-NAFLD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard diet (low in high fructose corn syrup)</intervention_name>
    <description>Subjects will consume a standard diet ( low in high fructose corn syrup)for 4 weeks.  The food will be prepared by the bionutrition kitchen and meals will be picked up every 3-4 days.</description>
    <arm_group_label>NAFLD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IHTG &gt;10% or &lt;5%

          -  BMI 30.0-45.0 kg/m2

          -  Sedentary

          -  Consume &lt;10% calories from high fructose corn syrup

          -  Weight stable for previous 3 months

        Exclusion Criteria:

          -  IHTG 5.1-9.9%

          -  Children

          -  Adults over 65 years

          -  Pregnant

          -  Lactating

          -  Exercise &gt;1.5 hours/week

          -  Hepatitis B or C

          -  Diabetes

          -  History of liver disease

          -  History of alcohol abuse

          -  Severe hypertriglyceridemia (&gt;300 mg/dl)

          -  Smokers

          -  Anemia (Hemoglobin &lt;10mg/dl)

          -  Not weight stable
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shelby A Sullivan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samuel Klein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martha A Hessler, CCRC</last_name>
    <phone>314-362-8703</phone>
    <email>mhessler@dom.wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melisa R Moore, RN,BSN</last_name>
    <phone>314-362-8604</phone>
    <email>mmoore@dom.wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Lake, BA</last_name>
      <phone>314-362-1000</phone>
      <email>elake@dom.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Shelby A Sullivan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samuel Klein, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 17, 2013</lastchanged_date>
  <firstreceived_date>December 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Nonalcoholic fatty liver disease</keyword>
  <keyword>High fructose corn syrup</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
